Quantinuum Files for IPO Quantum Computing Startup Targets 13 Billion Valuation Indias Gherkin Exports Reach Record 307 Million in FY26 Despite US Tariffs SpaceX Starship V3 Rocket Lifts Off in Historic Test Flight US Battery Module Manufacturing Capacity Sufficient for Domestic Demand ACP Claims Oil Stock Poised to Outperform Despite Potential Iran Deal Easing Energy Markets SpaceX Successfully Launches Starship on Second Attempt Advancing Reusable Rocket Program SOHON Q2 2025 Earnings Preferred Dividend Coverage Reported Positive Amid Quiet Quarter WD Q1 2026 Earnings Strong EPS Beat Amid Quiet Revenue Period SNFCA Q4 2025 Earnings Earnings per share of 053 reported stock edges lower FrancoNevada Q1 2026 Earnings EPS Beats Estimates by 137 Shares Edge Higher Gentherm Inc THRM Q1 2026 Earnings EPS Crushes Estimates Stock Rises BBNX Q1 2026 Earnings NarrowerThanExpected Loss Drives Slight Negative Reaction Envirotech Vehicles Inc EVTV Surges 1689 as Momentum Builds Above Key Support Nouveau Monde Graphite NMG Slides 25 as Selling Pressure Persists Key Support at 182 in Focus PDD Holdings Surges 224 Can Momentum Sustain Above Key Resistance Hecla Mining HL Rallies 384 as Silver Momentum Builds Pimco New York Municipal Income Fund II PNI Edges Higher Amid Stable Trading TPST Q1 2026 Earnings Significant EPS Miss Amid No Revenue Stock Gains 276 OXLCN Q4 2025 Earnings EPS Misses Estimates but Stock Edges Higher PALI Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Biotech Challenges Prudential Financial PRS Q1 2026 Earnings Strong EPS Beat Bolsters Credit Profile Amid Stable Market Response EGY Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment GFL Q1 2026 Earnings EPS Misses Estimates Amidst Cost Pressures Micron Technology Stands Out as a Contrarian Opportunity Amid AI and Energy Frenzy NTRA Q1 2026 Earnings EPS Misses Estimates Amid Cost Pressures Brookfield Renewable Partners BEP Holds Steady Near Resistance Amid Modest Decline DOW Q1 2026 Earnings EPS Surprises to the Upside Despite Negative Earnings Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline Curbline Properties Q1 2026 Earnings Miss on EPS Stock Edges Higher SWK Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Improvements PTCT Q1 2026 Earnings Narrower Loss Surprises Estimates as Stock Dips Slightly C4 Therapeutics Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline SWBI Q1 2026 Earnings EPS Surprises Despite Flat Market Reception